CDH2 and breast cancer: In our earlier studies, higher doses of Vitamin D3 were used (up to 1 mM range) and revealed the downregulation of glycolysis and mTOR, as well as the alteration of EMT pathway proteins (Vimentin, E-cadherin, and N-cadherin) and lowering breast cancer cell viability [59].